ALLO
Allogene Therapeutics, Inc. · Healthcare
SVP and General Counsel Earl Martin Douglas sold $63K of Allogene Therapeutics, Inc.
Sold$62,958
$2.12Price
29,697Shares
−6%Stake
What ALLO did after the filing
- The stock from Wed, Aug 26 open, $2.17
- −35.5%
- S&P 500, same days
- +1.2%
Measured over 30 trading days, to the Oct 8 close.
Traded Fri, Aug 21. Filed Tue, Aug 25, 4:43 PM ET, after the close. Returns use the Aug 26 open and the Oct 8 close. Not investment advice.